Teva Pulls Out Its Digital Inhaler GoResp From UK Market
GoResp Digihaler Is A Generic Rival To AstraZeneca’s Symbicort With A Digital Component
Executive Summary
Commercial reasons led Teva to withdraw its innovative GoResp Digihaler from the UK market, asking healthcare professionals to stop supplying the inhaler immediately.